<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-molecules-24-02603">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hachiya</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Reeve</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Marchand</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Michailidis</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ong</surname>
    <given-names>Y.T.</given-names>
   </name>
   <name>
    <surname>Kirby</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Leslie</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Oka</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kodama</surname>
    <given-names>E.N.</given-names>
   </name>
   <name>
    <surname>Rohan</surname>
    <given-names>L.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Evaluation of combinations of 4′-ethynyl-2-fluoro-2′-deoxyadenosine with clinically used antiretroviral drugs</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2013</year>
  <volume>57</volume>
  <fpage>4554</fpage>
  <lpage>4558</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00283-13</pub-id>
  <pub-id pub-id-type="pmid">23796932</pub-id>
 </element-citation>
</ref>
